Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed8
Other1

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT05067621Phase 2Active Not Recruiting
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Impaired Glucose ToleranceNon-Alcoholic Fatty Liver DiseaseObesity, Childhood+1 more
PrincipalinvestigatorStart date: 2023-07-17
NCT03195400Completed
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
IGT - Impaired Glucose ToleranceT2D
PrincipalinvestigatorStart date: 2017-03-01
NCT02310724Completed
TODAY2 Phase 2 Follow-up
Type 2 Diabetes
PrincipalinvestigatorStart date: 2014-03-01
NCT02004561Completed
Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries
Obese Adolescents
PrincipalinvestigatorStart date: 2012-01-01
NCT01901978Not ApplicableCompleted
Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents
Insulin ResistanceObesity
PrincipalinvestigatorStart date: 2011-05-01
NCT00409422Not ApplicableCompleted
Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children
HyperinsulinemiaInsulin ResistancePediatric Obesity
Principalinvestigator
NCT01364350Completed
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
Diabetes Mellitus Type 2 in Obese
Principalinvestigator

Research Network

Collaboration Network

29 collaborators·74 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Silva Arslanian, MD

University of Pittsburgh

Related
2 trials

Shared therapeutic areas:

Diabetes Mellitus Type 2 in ObeseDiabetes Mellitus, Type 2

Worked with same sponsors:

National Eye Institute (NEI)National Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 2 trials
Similarity Score28%

Kathryn Hirst, PhD

George Washington University

Related
3 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2Diabetes Mellitus Type 2 in Obese

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

David Nathan, MD

Massachusetts General Hospital

Related
2 trials

Shared therapeutic areas:

Diabetes Mellitus Type 2 in ObeseDiabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

Phil Zeitler, MD PhD

University of Colorado, Denver

Related
2 trials

Shared therapeutic areas:

Diabetes Mellitus Type 2 in ObeseDiabetes Mellitus, Type 2

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score24%

Leona Cuttler, MD

CWRU Rainbow Babies and Children's Hospital

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus Type 2 in Obese

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score14%

Jane Lynch, MD

The University of Texas Health Science Center at San Antonio

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus Type 2 in Obese

Worked with same sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborated on 1 trial
Similarity Score14%

Ruth S Weinstock, MD PhD

SUNY Upstate Medical Center

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

National Eye Institute (NEI)National Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score14%

Philip S Zeitler, MD PhD

University of Colorado Denver Children's Hospital

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

National Eye Institute (NEI)National Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score14%

David M Nathan, MD

Massachusetts General Hospital

Related
4 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

National Eye Institute (NEI)National Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score14%

Lorraine L Katz, MD

Children's Hospital of Philadelphia

Related
1 trials

Shared therapeutic areas:

Diabetes Mellitus, Type 2

Worked with same sponsors:

National Eye Institute (NEI)National Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT05067621Phase 2PrincipalInvestigator

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Impaired Glucose ToleranceNon-Alcoholic Fatty Liver DiseaseObesity, Childhood+1 more
Active Not Recruiting
NCT03195400PrincipalInvestigator

Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes

IGT - Impaired Glucose ToleranceT2D
Completed
NCT02310724PrincipalInvestigator

TODAY2 Phase 2 Follow-up

Type 2 Diabetes
Completed
NCT02004561PrincipalInvestigator

Comparison Between Gastric Band, Laparoscopic Sleeve Gastrectomy, Gastric Bypass Surgeries

Obese Adolescents
Completed
NCT01901978Not ApplicablePrincipalInvestigator

Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents

Insulin ResistanceObesity
Completed
NCT00409422Not ApplicablePrincipalInvestigator

Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children

HyperinsulinemiaInsulin ResistancePediatric Obesity
Completed
NCT00585299Not ApplicablePrincipalInvestigator

Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD

Fatty LiverInsulin Resistance
Completed
NCT01364350PrincipalInvestigator

TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study

Diabetes Mellitus Type 2 in Obese
Completed
NCT02395003PrincipalInvestigator

Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents

Pediatric Obesity
Completed

All 9 trials loaded